GleamWall
中文EN

MEDS DataMeds AI, Inc.

Wholesale-Drugs, Proprietaries & Druggists' Sundries · Nasdaq · SEC CIK 2030763 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-77.5%
TTM net income YoY44.2%
TTM EPS YoY187.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin-92.1%
Operating margin-548.1%
Net margin-564.8%
FCF margin—
EBITDA margin-523.7%

Returns

ROE-1,706.7%
ROA-94.8%
ROIC (approx.)-153.4%
Asset turnover0.17x

Leverage & solvency

Liabilities / assets99.6%
Debt / equity—
Current ratio0.14x
Interest coverage-6.22x

Cash quality & payout

Operating cash flow / net income0.36x
Accruals ratio-60.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$23.34M$18.13M
Cost of revenue$29.76M$16.36M
Gross profit-$6.43M$1.77M
SG&A expense$70.33M$6.80M
Operating income-$93.75M-$6.15M
Interest expense$4.58M$831,467
Pretax income-$101.27M-$6.86M
Net income-$101.27M-$6.86M
EBITDA-$90.54M-$5.03M
EPS (basic)-1.43-0.15
EPS (diluted)-1.43-0.15
Weighted avg. shares (diluted)70.99M47.25M
Balance sheet
Cash & equivalents$42,571$1.03M
Receivables$1.14M—
Inventory$1.64M$9.52M
Current assets$2.82M$15.17M
PP&E, net$229,376$388,180
Goodwill$14.19M$16.22M
Intangibles$2.50M$1.62M
Total assets$30.46M$57.33M
Current liabilities$29.78M$38.05M
Short-term debt$10.89M$11.93M
Long-term debt$12.60M$11.46M
Total debt$23.49M$23.38M
Total liabilities$42.91M$50.60M
Shareholders' equity-$12.45M$6.73M
Net debt$23.44M$22.35M
Shares outstanding2.03M51.06M
Cash flow statement
Operating cash flow-$10.86M-$1.22M
Investing cash flow-$881,526$469,072
Financing cash flow$10.75M$1.78M
Depreciation & amortization$3.21M$1.11M
Stock-based compensation$54.79M$1.08M

Free plan shows the latest 2 periods; Pro shows all 3 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.